Total Payments
$914.60
2024 Payments
$24.45
Companies
12
Transactions
51
Medicare Patients
106
Medicare Billing
$1,163
Payment Breakdown by Category
Food & Beverage$868.22 (94.9%)
Education$32.27 (3.5%)
Other$14.11 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $868.22 | 49 | 94.9% |
| Education | $32.27 | 1 | 3.5% |
| Debt forgiveness | $14.11 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $257.96 | 7 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $177.10 | 13 | $0 (2022) |
| Novo Nordisk Inc | $157.68 | 11 | $0 (2023) |
| GlaxoSmithKline, LLC. | $70.79 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $67.30 | 4 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $64.95 | 4 | $0 (2022) |
| SANOFI PASTEUR INC. | $44.30 | 2 | $0 (2024) |
| AbbVie Inc. | $20.24 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.96 | 1 | $0 (2021) |
| Baxter Healthcare | $14.11 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.45 | 1 | SANOFI PASTEUR INC. ($24.45) |
| 2023 | $32.82 | 2 | SANOFI PASTEUR INC. ($19.85) |
| 2022 | $132.73 | 9 | Novartis Pharmaceuticals Corporation ($35.70) |
| 2021 | $128.40 | 8 | GlaxoSmithKline, LLC. ($31.24) |
| 2020 | $14.09 | 1 | Novo Nordisk Inc ($14.09) |
| 2019 | $23.08 | 2 | Novo Nordisk Inc ($11.67) |
| 2018 | $107.48 | 5 | PFIZER INC. ($55.30) |
| 2017 | $451.55 | 23 | PFIZER INC. ($191.25) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/12/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Vaccines | ||||||
| 08/16/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Diabetes | ||||||
| 08/14/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Vaccines | ||||||
| 10/19/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/11/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/27/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: DIABETES | ||||||
| 05/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Diabetes | ||||||
| 04/27/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 01/19/2022 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $14.11 | General |
| 12/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Respiratory | ||||||
| 10/25/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Diabetes | ||||||
| 08/05/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 02/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
| 08/12/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: GASTROINTESTINAL | ||||||
| 04/01/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Diabetes | ||||||
| 10/25/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $55.30 | General |
| Category: DERMATOLOGY | ||||||
| 06/27/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 16 | $240.00 | $54.56 |
| 2022 | 4 | 46 | 52 | $1,548 | $657.54 |
| 2021 | 2 | 31 | 40 | $1,044 | $257.57 |
| 2020 | 1 | 16 | 20 | $798.50 | $193.63 |
Total Patients
106
Total Services
128
Medicare Billing
$1,163
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 16 | $240.00 | $54.56 | 22.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 13 | $520.00 | $453.62 | 87.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 14 | $498.80 | $134.12 | 26.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 14 | $210.00 | $48.15 | 22.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 11 | 11 | $319.00 | $21.65 | 6.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 15 | 19 | $728.50 | $184.49 | 25.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 16 | 21 | $315.00 | $73.08 | 23.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 16 | 20 | $798.50 | $193.63 | 24.2% |
About Dr. Mark Kaplan, DO
Dr. Mark Kaplan, DO is a Emergency Medicine healthcare provider based in Ellsworth, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861498461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Kaplan, DO has received a total of $914.60 in payments from pharmaceutical and medical device companies, with $24.45 received in 2024. These payments were reported across 51 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($868.22).
As a Medicare-enrolled provider, Kaplan has provided services to 106 Medicare beneficiaries, totaling 128 services with total Medicare billing of $1,163. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Ellsworth, ME
- Active Since 06/28/2005
- Last Updated 09/11/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861498461
Products in Payments
- CHANTIX (Drug) $140.27
- SOLIQUA (Drug) $121.98
- Victoza (Drug) $66.75
- TRELEGY ELLIPTA (Drug) $58.77
- EUCRISA (Drug) $55.30
- Ozempic (Drug) $54.51
- ELIQUIS (Drug) $50.98
- ENTRESTO (Drug) $47.02
- BEVESPI AEROSPHERE (Drug) $33.05
- SOLIQUA 100/33 (Biological) $29.96
- BEYFORTUS (Biological) $24.45
- BREZTRI (Drug) $20.76
- VRAYLAR (Drug) $20.24
- FLUZONE HIGH-DOSE (Biological) $19.85
- LEQVIO (Drug) $17.93
- VYVANSE (Drug) $16.96
- Rybelsus (Drug) $13.36
- TOUJEO (Drug) $12.64
- TOUJEO (Biological) $12.52
- JARDIANCE (Drug) $12.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.